MAGE-A3-Targeted Autologous CD4+ T Cells May Target Metastatic Cancer [Clinical Trials]

Adoptive transfer of MAGE-A3–targeted CD4⁺ T cells is safe and achieves responses in several tumor types.

from Cancer via ola Kala on Inoreader http://ift.tt/2wu0yDp
via IFTTT